Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles

Cunjin Luo,Kuanquan Wang,Tong Liu,Henggui Zhang

DOI: https://doi.org/10.1109/embc.2018.8513572

2018-01-01

Abstract:Aims: The short QT syndrome (SQTS) is a rare genetic disorder associated with arrhythmias and sudden cardiac death (SCD). The SQT1 and SQT3, SQTS variants, result from gain-of-function mutations (N588K and D172N, respectively) in the KCNH2-encoded and KCNJ2-encoded potassium channels, in which treatment with potassium channel blocking agents has demonstrated some efficacy. This study used in silico modelling to gain mechanistic insights into the actions of anti-malarial drug chloroquine (CQ) in the setting of SQT1 and SQT3. Methods and Results: The ten Tusscher et al. human ventricle model was modified to a Markov chain formulation of I-Kr and a Hodgkin-Huxley formulation of I-K1 describing SQT1 and SQT3 mutant conditions, respectively. Cell models were incorporated into heterogeneous one-dimensional (1D) transmural ventricular strand model to assess prolongation of the QT intervals. The blocking effects of CQ on I-K1 and I-Kr were modelled by using Hill coefficient and IC50 from literatures. At the single cells, CQ prolonged the AP duration (APD) under both the SQT1 and SQT3 conditions; at the multi-cell strand level, CQ prolonged the QT intervals and declined the T-wave amplitude under both conditions. Conclusions: This computational study provides novel insights into the efficacy of CQ in the setting of SQT1 and SQT3 variants, and indicates that CQ is a useful drug in the treatment of SQTS.